期刊文献+

血清PSA检测的方法学评价

A methodological evaluation on serum PSA test
下载PDF
导出
摘要 目的对时间分辨荧光免疫法(TRFIA)测定血清总前列腺特异性抗原(tPSA)和游离前列腺特异性抗原(fPSA)的方法学予以评价,评价TRFIA法测定血清总前列腺特异性抗原(tPSA)和游离前列腺特异性抗原(fPSA)灵敏度、精密度、回收试验及与化学发光免疫法(CLEIA)的相关性。方法采用重复性试验、回收试验、比较试验方法。结果tPSA和fPSA检测下限分别为0.02μg/L和0.05μg/L,批内变异系数分别为2.38%、3.16%,回收率分别为101.2%和102.4%,与CLEIA法高度相关,r值分别为0.986和0.964。结论TRFIA测定tPSA和fPSA稳定性好、灵敏度和准确度高,是当前免疫最有发展前途的超微量检测技术。 Objective To evaluate the method of time-resolved fluoroimmunoassay (TRFIA) for serum total prostate specific antigen (tPSA) with free prostate specific antigen(fPSA) and compare TRFIA with chemiluminescent enzyme immunoassay ( CLEIA) for the assay of tPSA and fPSA in the sensitivity, precision and recovery rate. Methods Repeat test,callback test and compatison test. Results The lower limits of tPSA and fPSA were 0.02μg/L and 0. 05 μg/L respectively. The CV within were 2.38% and 3. 16% respectively. The recovery rates were 101.2% and 102.4% respectively. Being in high agreement with CLEIA, the values of r was 0.986 and 0. 964. Conclusion The sensitivity of TRFIA for serum tPSA and fPSA is high. It is also highly accurate. TRFIA appears to be a useful biochemical uhrami croanalysis technique worthy of further development.
作者 冯恒荣
出处 《淮海医药》 CAS 2009年第1期18-20,共3页 Journal of Huaihai Medicine
关键词 前列腺肿瘤 时间分辨荧光免疫法 前列腺特异性抗原 FPSA/TPSA比值 Prostatic neoplasms Time-resolved fluoroimmunoassay Prostate specific antigen Free/total PSA ratio
  • 相关文献

参考文献7

  • 1胡恩赑,谷明莉.fPSA、TPSA及其比值在前列腺癌鉴别诊断中的应用评价[J].淮海医药,2007,25(2):114-115. 被引量:3
  • 2沈关心,周汝麟.现代免疫学实验技术[M].武汉:湖北科技出版社,1988.94-142.
  • 3Storch MJ, Marbaeh P, Karp L. A time-resolved fluoroimmunoassay for human insulin based on two monoelonal antibodies[ J]. J lmmunol Methods,1993,157( 1 -2) :197-201.
  • 4Stenman J, Aljfthan H, Stenman UH, Streptavidin-biotin based time-resolved fluoroimmunoassay for direct measurement of concentrations of human chorionic gonadotrepin (HCG) [ J ]. J Immunol Methods, 1994,175 (2) : 161-167.
  • 5Wu F,Xu Y,Xu T. Time-resolved fluomimmunoassay of thyroxine in serum : immobilized antig ;n approach [ J ]. Anal Biochem, 1999,276 (2) :171-176.
  • 6Sorensen T, Spenter J, Jaliashvili I, et al. Automated time-resolved fluoroimmunoassay for Toxoplasma gondi-specific IgM and IgA antibodies : study of more than 130,000 filter-paper blood-spot samples from newborns[ J]. Clin Chem ,2002,48 ( 11 ) : 1981-1986.
  • 7李振甲.放射免疫技术的研究现状与前景[J].标记免疫分析与临床,2000,7(3):156-160. 被引量:13

二级参考文献13

  • 1李振甲,陈素娟,王录焕,陈泮藻.试管固相RIA和IRMA技术的实验研究[J].中国免疫学杂志,1993,9(4):223-225. 被引量:5
  • 2李振甲,高平.标记免疫检验技术研究的新进展[J].中华医学检验杂志,1994,17(5):308-310. 被引量:8
  • 3李振甲.试管固相放射免疫技术研究中有关问题的探讨[J].标记免疫分析与临床,1994,1(2):100-103. 被引量:7
  • 4杨全成,李凯,张晓光,齐士勇.f/T-PSA比值和PSA密度对TPSA灰区前列腺癌的诊断意义[J].现代肿瘤医学,2006,14(2):188-190. 被引量:7
  • 5CausseJE,RicoredelI,BacheierMN,etal.RadioimmunologicaldeterminationoftotalthyroxinbyantibodiesimmobilizedonpolystrentubesCoatedwithstyren-maleicanhydridecopolymers[J].ClinChem,1990,36:525.
  • 6OsmansS,TurpeinenU,IskonenO,etal.OptimizationofaTRIFMAfortumor-associatedtrypsininibitorusingthestreptavidin-biotinsystem[J].JImmunolMethods,1998,110:31.
  • 7Sanchczc-carbayM,EspzsaA,ChinchllV,etal.NewelectrochemilumiluminescentimmunoassayforthederterminationofCYRA21-1:analyticaleraluationandclinicaldiagnosticperformanceinurinesamplesofpatientswithbiaddercancer[J].ClinChem,1999,45:1944.
  • 8Iwata,HayashiT,NakaoY,etal.DirectderterminationofplasmaET-1bychemiluminescenceenzymeimmunoassay[J].ClinChem,1996,42:1155.
  • 9Catalone WJ,Southwick PC,Slawin KM,et al.Comparison of percent free PSA,PSA density,and age specific PSA cutoffs for prostate cancer detection and staging[J].Urology,2000,56(2):255-260.
  • 10Mccormack RT,Rittenhouse HG.Molecular forms of prostate specific anigen and the human kallikrein gene family:a new era[J].Urology,1995,45(5):729-744.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部